Autism-Linked Gene SYNGAP1 Molds Synaptic Plasticity, Learning

The finding may help to explain why people with SYNGAP1 mutations tend to have learning difficulties and a high tolerance for pain.

Written byAngie Voyles Askham and Spectrum
| 4 min read
SYNGAP1 helps neurons eliminate old synapses and form new ones after a novel experience (left and center left)—a process weakened in mice missing a copy of the gene (center right and right).
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Even partial loss of the autism-linked gene SYNGAP1 impairs the brain’s ability to respond to sensory experiences, according to a new study in mice. The finding may help to explain why people with SYNGAP1 mutations tend to have learning difficulties and a high tolerance for pain.

The SYNGAP1 protein abounds at excitator synapses and shapes plasticity there, helping neighboring neurons to strengthen or weaken their connections. But it was previously unclear how SYNGAP1 affects ‘ensembles,’ groups of neurons with coordinated activity that are considered the “direct neural correlate of behavior and thought,” says lead researcher Gavin Rumbaugh, professor of neuroscience at Scripps Research in Jupiter, Florida.

To encode new information about a sensory experience, a neuronal ensemble needs to redistribute its activity: Some neurons ramp up their chatter while others dial it down, keeping the group’s overall activity the same. “It’s learning, basically,” Rumbaugh says.

That redistribution is defunct in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies